News

Will 100% coverage spur more use of breast cancer chemopreventives?

Publish date: January 22, 2014

 

On Twitter @aliciaault

Pages

Recommended Reading

Exercise dampens aromatase inhibitor–related joint pain
MDedge Family Medicine
SABCS Roundtable with Dr. Howard Burris and Dr. William Gradishar
MDedge Family Medicine
No survival benefit to bisphosphonate in chemoresistant breast cancer
MDedge Family Medicine
New mega-review underscores mammography’s benefits
MDedge Family Medicine
'Vogl, New York' offers San Antonio perspectives
MDedge Family Medicine
Breast MRI screening finds undetected cancers in 11 per 1,000 average-risk women
MDedge Family Medicine
Exercise protects black women against ER-negative breast cancer
MDedge Family Medicine
Primary care screening advised to select women for BRCA counseling
MDedge Family Medicine
No overall benefit seen with bisphosphonate treatment in chemoresistant breast cancer
MDedge Family Medicine
Survival no better after primary tumor removal in metastatic breast cancer
MDedge Family Medicine